EMEA-002196-PIP01-17
Key facts
| Active substance |
Human Neutrophil Elastase Inhibitor (CHF6333)
|
| Therapeutic area |
Pneumology-allergology
|
| Decision number |
P/0367/2017
|
| PIP number |
EMEA-002196-PIP01-17
|
| Pharmaceutical form(s) |
Pressurised inhalation, suspension
|
| Condition(s) / indication(s) |
Treatment of bronchiectasis
|
| Route(s) of administration |
Inhalation use
|
| Contact for public enquiries |
Chiesi Farmaceutici S.p.A
Tel. +39 05212791 |
| Decision type |
RW: decision refers to a refusal on a request for waiver in all age groups for the listed condition(s)
|